Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 in acute uncomplicated malaria
NCT01213966Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of artefenomel in Plasmodium falciparum malaria and malaria (4 arms), sponsored by Medicines for Malaria Venture. Primary endpoint: Derived Parasite Reduction Rate at 24 Hours. Started Oct 2010; status: completed.
02
Drugs
artefenomel
03
Conditions
Plasmodium falciparum malariamalaria
Beyond the preview
Go deeper on NCT01213966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213966.